Table of Content

1 Biosimilars Market Introduction and Overview
1.1 Biosimilars Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Biosimilars Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Biosimilars Revenue and Market Share by Type
3 Global Biosimilars Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Biosimilars Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Biosimilars Market Size (2019-2024)
4.2 Biosimilars Growth Trends Analysis by Regions
4.2.1 Biosimilars Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Biosimilars Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Biosimilars Market Size (2019-2024)
4.2.4 Europe Biosimilars Market Size (2019-2024)
4.2.5 Asia-Pacific Biosimilars Market Size (2019-2024)
4.2.6 Latin America Biosimilars Market Size (2019-2024)
4.2.7 Middle East & Africa Biosimilars Market Size (2019-2024)
5 North America
5.1 North America Biosimilars Revenue by Countries
5.1.1 North America Biosimilars Revenue by Countries (2019-2024)
5.2 North America Biosimilars Revenue by Types
5.3 North America Biosimilars Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Biosimilars Revenue by Countries
6.1.1 Asia Pacific Biosimilars Revenue by Countries (2019-2024)
6.2 Asia Pacific Biosimilars Revenue by Types
6.3 Asia Pacific Biosimilars Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilars Revenue by Countries
7.1.1 Europe Biosimilars Revenue by Countries (2019-2024)
7.2 Europe Biosimilars Revenue by Types
7.3 Europe Biosimilars Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Biosimilars Revenue by Countries
8.1.1 Latin America Biosimilars Revenue by Countries (2019-2024)
8.2 Latin America Biosimilars Revenue by Types
8.3 Latin America Biosimilars Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Biosimilars Revenue by Countries
9.1.1 Middle East & Africa Biosimilars Revenue by Countries (2019-2024)
9.2 Middle East & Africa Biosimilars Revenue by Types
9.3 Middle East & Africa Biosimilars Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Biosimilars Market Competition, by Players
10.1 Global Biosimilars Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Biosimilars Players Market Share in 2023
10.2.2 Top 6 Biosimilars Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Biosimilars Players Head Office, Business Provided
10.4 Biosimilars Mergers & Acquisitions
10.5 Biosimilars New Entrants and Expansion Plans
11 Players Profiles11.1 Biocon
11.1.1 Biocon Company Profile
11.1.2 Biosimilars Product Overview
11.1.3 Biocon Biosimilars Market Performance (2019-2024)
11.1.4 Biocon Business Overview
11.1.5 Recent Developments and Plans
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Profile
11.2.2 Biosimilars Product Overview
11.2.3 Teva Pharmaceutical Biosimilars Market Performance (2019-2024)
11.2.4 Teva Pharmaceutical Business Overview
11.2.5 Recent Developments and Plans
11.3 Amgen
11.3.1 Amgen Company Profile
11.3.2 Biosimilars Product Overview
11.3.3 Amgen Biosimilars Market Performance (2019-2024)
11.3.4 Amgen Business Overview
11.3.5 Recent Developments and Plans
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Profile
11.4.2 Biosimilars Product Overview
11.4.3 Roche Diagnostics Biosimilars Market Performance (2019-2024)
11.4.4 Roche Diagnostics Business Overview
11.4.5 Recent Developments and Plans
11.5 Merck KGaA
11.5.1 Merck KGaA Company Profile
11.5.2 Biosimilars Product Overview
11.5.3 Merck KGaA Biosimilars Market Performance (2019-2024)
11.5.4 Merck KGaA Business Overview
11.5.5 Recent Developments and Plans
11.6 Celltrion
11.6.1 Celltrion Company Profile
11.6.2 Biosimilars Product Overview
11.6.3 Celltrion Biosimilars Market Performance (2019-2024)
11.6.4 Celltrion Business Overview
11.6.5 Recent Developments and Plans
11.7 Hospira
11.7.1 Hospira Company Profile
11.7.2 Biosimilars Product Overview
11.7.3 Hospira Biosimilars Market Performance (2019-2024)
11.7.4 Hospira Business Overview
11.7.5 Recent Developments and Plans
11.8 Mylan
11.8.1 Mylan Company Profile
11.8.2 Biosimilars Product Overview
11.8.3 Mylan Biosimilars Market Performance (2019-2024)
11.8.4 Mylan Business Overview
11.8.5 Recent Developments and Plans
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Profile
11.9.2 Biosimilars Product Overview
11.9.3 Dr. Reddy's Laboratories Biosimilars Market Performance (2019-2024)
11.9.4 Dr. Reddy's Laboratories Business Overview
11.9.5 Recent Developments and Plans
11.10 Sandoz International
11.10.1 Sandoz International Company Profile
11.10.2 Biosimilars Product Overview
11.10.3 Sandoz International Biosimilars Market Performance (2019-2024)
11.10.4 Sandoz International Business Overview
11.10.5 Recent Developments and Plans
12 Global Biosimilars Forecast Market Analysis by Type
12.1 Global Biosimilars Revenue Market Forecast by Type (2024-2030)
13 Global Biosimilars Forecast Market Analysis by Application
13.1 Biosimilars Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Biosimilars Forecast Market Size (2024-2030)
14.2 Biosimilars Growth Trends Forecast Analysis by Regions
14.2.1 Biosimilars Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Biosimilars Forecast Market Size (2024-2030)
14.2.3 Europe Biosimilars Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Biosimilars Forecast Market Size (2024-2030)
14.2.5 Latin America Biosimilars Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Biosimilars Forecast Market Size (2024-2030)
15 Biosimilars Industry Dynamic Analysis
15.1 Biosimilars Market Trends Analysis
15.2 Biosimilars Market Drivers Analysis
15.3 Biosimilars Market Challenges Analysis
15.4 Biosimilars Market Restraints Analysis